Among patients treated with NAC for early-stage BC, residual nodal disease, inflammatory BC, and HER2+ or triple-negative subtype are associated with a higher risk of BrM development and whether BrM screening is warranted among patients with these high-risk features warrants evaluation.
An internally validated prediction model for BrM in GI cancers developed and validated performance in a held-out cohort to develop a clinically interpretable prediction model.
M. V. Barcelona, K. Kataki, F. A. Rahman et al.· British Journal of Cancer· 0 citations
Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-related death among women. It is a biologically heterogeneous disease resulting from a multifactorial process. Neoadjuvant chemotherapy (NACT) has become a key treatment for patients with locally advanced or high-risk early-stage...
Olfa Aissa, Aicha Rabah, A. Bousahba et al.· ecancermedicalscience· 0 citations
Background Triple-negative breast cancer (TNBC) is known for its heterogeneity. Due to the small sample sizes in prior studies, there is limited understanding of whether different molecular subtypes have distinct predictive values following comprehensive treatment. Methods Females with TNBC treated with neoadjuvant che...
S. Shao, Wei Shi, Li Zhang et al.· Frontiers in Oncology· 0 citations
This study explores the role of clinical factors in influencing relapse-free survival (RFS) in breast cancer patients through comprehensive survival analysis (SA). The data were derived from a large cohort of breast cancer patients, encompassing clinical variables such as age at diagnosis, tumor size, number of positiv...
Boby Al Qurthuby, I. M. Murwantara· International Journal of Adv...· 0 citations
BACKGROUND
The role of liver-directed therapy in breast cancer liver metastases (BCLM) remains controversial, and evidence guiding patient selection is limited. This study aimed to characterize patients undergoing local treatment for BCLM and identify prognostic factors associated with outcomes.
METHODS
In this natio...
L. Mikkelsen, L. R. Jensen, A. Bjerrum et al.· Surgical oncology· 0 citations
Background and objectives: Neoadjuvant chemotherapy has become a commonly used method of treatment for individuals diagnosed with breast cancer. It involves administering it before surgery or radiation therapy, aiming to shrink tumors and possibly enhance surgical results. This study evaluates the impact of Neoadjuvant...
Iman Abdulhakim Dawod Dawod, R. Abduljabbar, R. Othman· Advanced medical journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
